National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares vs Nuwellis Inc — how do they compare? National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares trades at $79.7 (market cap $78.99B), while Nuwellis Inc trades at $0.54 (market cap $1.68M). The key difference: National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares is far larger — about 47017.9× Nuwellis Inc's market cap, and National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares pays a 4.13% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NGG | NUWE | |
|---|---|---|
Market Cap | $78.99B | $1.68M |
Volume | 740,402 | 375,944 |
Sector | Utilities | Health |
52-Week High | $93.93 | $146.65 |
52-Week Low | $73.54 | $0.53 |
Enterprise Value | $137.22B | -$2.03M |
Dividend Yield | 4.13% | — |
Typical Hold Time | — | 27 Days |
Signals from Pluang's Aura AI — not financial advice
National Grid (NGG) trades at $78.23, up 1.44% on the day, with a market cap of approximately $48.3 billion. The stock shows stable technicals near its consensus price target of $79.25. Fundamentally, it maintains strong profitability with an 18.32% net income margin and has beaten EPS estimates in recent quarters. Recent news highlights institutional buying and a focus on grid innovation, including AI adoption.
Outlook is cautiously positive with upside to the high target of $85.50, supported by earnings momentum and strategic investments. Risks include high debt levels and regulatory pressures. Analyst consensus leans buy (55%), but hold ratings reflect concerns over capital intensity and macroeconomic sensitivity.
NUWE trades at $0.621, down 7.35% today, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth with 2026 revenue reaching $9M, but continues to post significant losses with a -125.63% net income margin. Recent positive developments include strong Aquadex console adoption and expanded pediatric footprint, though cash flow remains negative requiring ongoing financing.
The outlook remains challenging with persistent losses and negative cash flow offset by promising commercial momentum. Investment opportunity hinges on the company's ability to achieve profitability while risks include execution challenges and dependence on financing. Analyst sentiment is mixed with equal buy/hold ratings reflecting the high-risk, high-reward nature of this medical technology stock.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
National Grid plc is a British utility company that owns and operates electricity and gas transmission networks in Great Britain, and through its US Regulated business, operates electricity and gas transmission and distribution networks serving customers in New York and Massachusetts. Its shares trade on the NYSE as American Depositary Shares under the ticker NGG.
Read more on NGG →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →